Ceftobiprole: a new broad spectrum cephalosporin. - Wikidata - awgldk - TriplyDB

Ceftobiprole: a new broad spectrum cephalosporin.

Ceftobiprole: a new broad spectrum cephalosporin.

http://www.wikidata.org/entity/Q37519733

about

Ceftobiprole for the treatment of pneumonia: a European perspective A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus Antibiotics and bacterial resistance in the 21st century.Newer antibacterials in therapy and clinical trials Emerging agents to combat complicated and resistant infections: focus on ceftobiprole Epidemiology of antimicrobial resistance in bloodstream infections.Emerging drugs in sepsis.Antibiotic management of febrile neutropenia: current developments and future directions.Will new antimicrobials overcome resistance among Gram-negatives?

P2860

Q26796463-AFB38D06-3E4A-47B4-80D4-AB2D1814BCCB Q28741367-936C137D-CB32-470D-8A5B-BE3ADC5783CB Q34156349-81897314-E73A-46D7-8747-724DB1CE0E52 Q34488329-8C9AE837-DEA8-47C6-ADB7-63E19024F49F Q35026567-5EA125E6-5B97-44C6-84E9-08915EF8AB06 Q36913239-EE825074-46DF-45B1-9464-DA9CA78152C7 Q37670186-9C7A31DB-0098-469C-BFF9-E603CC6CB6EA Q37708866-F9461A42-E4F2-4FDE-B508-C492D0F2260A Q37942654-031697BC-409B-458A-A229-E4E6EFC6E5B4

P2860

Ceftobiprole: a new broad spectrum cephalosporin.

http://www.wikidata.org/entity/Q37519733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ceftobiprole: a new broad spectrum cephalosporin.

@en

Ceftobiprole: a new broad spectrum cephalosporin.

@nl

type

label

Ceftobiprole: a new broad spectrum cephalosporin.

@en

Ceftobiprole: a new broad spectrum cephalosporin.

@nl

prefLabel

Ceftobiprole: a new broad spectrum cephalosporin.

@en

Ceftobiprole: a new broad spectrum cephalosporin.

@nl

P1433

Q37519733-B0352C00-7297-468E-896C-E9BE42A0C51D

P1476

Q37519733-D89EACDC-A63A-4C05-B982-9567F43C6ED5

P2093

Q37519733-D9836474-C569-4BBA-B1F2-080B4BA29551

P2860

Q37519733-02789767-C929-4F46-B260-0D98425612E7

Q37519733-039C5753-8882-4A8F-8BE7-B662D61CBE21

Q37519733-0AF9954D-0855-4BD2-ACD3-97BD4701A067

Q37519733-0E008DCE-04F2-46A5-AAD7-076740F4E548

Q37519733-15B2E3C6-CE4C-4CF3-8178-D1DA695D826E

Q37519733-17505931-18B4-4963-ABAB-C9F17FD1BDD4

Q37519733-181F6E72-CCBD-442C-92F4-12045EF57CF2

Q37519733-2193FD03-2097-424B-8513-A0EDD432F61C

Q37519733-24B548A1-4D70-48CA-B290-128B94A29960

Q37519733-2F4BE0AA-3605-4D4A-A3A6-7C176EEC8879

P304

Q37519733-0CBD4B60-A16E-4805-844F-75CF73250D61

P31

Q37519733-4226D436-6AE0-4F6C-8C2F-E2BD02436FA0

P356

Q37519733-C63DDFCA-3918-4BF5-A691-58FA36612BBC

P407

Q37519733-6F855B61-8A3A-4B63-B159-3E8AB2E45419

P433

Q37519733-F57D0160-1377-4DD3-A029-6DE7EFEC1FA4

P478

Q37519733-29EA6D10-392C-49DD-8875-DEAC905EBEF6

P577

Q37519733-D3CB2C6F-70BB-4385-957D-DE6E3899465D

P698

Q37519733-EE0FDE9D-D89F-4F5E-AD8D-3AFC85045BCD

P356

14656560903048967

P1433

Expert Opinion on Pharmacotherapy

P1476

Ceftobiprole: a new broad spectrum cephalosporin.

@en

P2093

Ali El Solh

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.

Investigational new drugs for the treatment of resistant pneumococcal infections.

P304

1675-1686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656560903048967

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19527192

http://www.w3.org/2001/XMLSchema#string